INTRODUCTION {#sec2010}
============

Demographic aging is a worldwide phenomenon and number of people with dementia are increasing rapidly \[[@ref001]\]. In low- and middle-income countries (LMICs), dementia cases are expected to more than triple by 2050 \[[@ref001]\]. Latin America have a high prevalence of dementia (standardized prevalence = 8.3), compared to, for example, North America (5.7), Asia (5.6--7.7), Africa (4.6), and Europe (4.7--6.7) \[[@ref002]\]. In addition, depression is a common condition in late-life \[[@ref003]\], and population-based studies report that as many as one third of older adults in LMICs and Latin America could be affected by depressive syndromes \[[@ref004]\].

A growing body of evidence suggests that late-life depression is related to onset of dementia. Several epidemiological studies have observed this relationship and meta-analyses have repeatedly reported a two-fold higher risk for dementia in people with depression \[[@ref006]\]. The characteristics of this relationship are not yet sufficiently understood and some studies report contradictory results, i.e., that depression has no effect of the trajectory of dementia \[[@ref010]\]. While progress has been made, a glaring omission in the literature shows that almost all prior studies on this topic have been conducted in high-income countries. According to the latest systematic review, only one study was carried out in a middle-income country, i.e., in China \[[@ref009]\].

The association between depression and onset of dementia can be explained in several ways. Depression can be a trigger for damaging neuropathological processes in the brain, e.g., through alterations in the nervous, vascular, and inflammatory systems \[[@ref012]\]. Episodes of severe depression have earlier been associated with pathological changes in specific regions in the brain, e.g., in the prefrontal cortex, \[[@ref013]\] in the hippocampus area \[[@ref014]\], and in sub-cortical white matter \[[@ref015]\]. Symptoms of depression may also be a psychological reaction to a cognitive and functional decline, or reflect a prodromal state of dementia.

While existing studies on the association between depression and dementia show inconsistency and mainly have been carried out in high-income countries \[[@ref006]\], it is not known whether this relation can be found in other settings. The aim of this study was to examine the association between depression and incidence of dementia over a 4-year follow-up period, in a large population-based sample of older people living in six LMICs in Latin America.

METHODS {#sec2015}
=======

Setting and participants {#sec2020}
------------------------

The analyses originate from the 10/66 Dementia Research Group population-based survey, which include persons aged≥65 years living in geographically defined catchment areas in urban and rural sites in Latin America \[[@ref001]\]. Baseline examinations were carried out between 2003 and 2007 (depending on site) and included clinical interviews, physical examinations, and informant interviews, which generated information about, e.g., cognitive and mental disorders, physical health, socio-demographic factors, disability, and use of health services. Trained interviewers examined the participants' in their own homes (2-3 hours) and all instruments were translated, back translated, and assessed for acceptance and conceptual equivalence \[[@ref017]\]. The follow-up examinations were conducted 3 to 5 years after baseline and were essentially a repeat of the first examination. The 10/66 study has earlier been described in details \[[@ref001]\].

Persons with dementia at baseline (*n* = 1,441) were removed from all analyses. Of the remaining 11,472 persons, 7,857 participated in the follow-up examination (2,160 were lost to follow up and 1,475 had deceased). Postmortem informant interviews were done in the majority of people who were deceased (*n* = 1,455, 99%), using the World Health Organization's "*Standard Verbal Autopsy Questionnaire 3: Death of a Person Aged 15 Years and Above*", as described elsewhere \[[@ref018]\]. The final analyses included 9,312 participants from Cuba (*n* = 2,339), Dominican Republic (*n* = 1,441), Peru (*n* = 1,328), Venezuela (*n* = 1,353), Mexico (*n* = 1,521), and Puerto Rico (*n* = 1,374). (See flow-chart in [Fig. 1](#jad-69-jad190148-g001){ref-type="fig"}.) All subjects provided informed consent to participate, either by themselves or through their next-of-kin. The data collection and study procedure were approved by the local ethics committees and by the King's College; London Research Ethics Committee.

![Flow-chart of participants at baseline and follow-up.](jad-69-jad190148-g001){#jad-69-jad190148-g001}

Diagnosis of depression {#sec2025}
-----------------------

Two definitions of depression were used: (I) *ICD-10 depression* (code F32) \[[@ref019]\] and (II) *sub-syndromal depression* (≥4 symptoms in the EURO-D scale, but not fulfilling the ICD-10 criteria). Both ICD-10 and EURO-D items were drawn from the semi-structured Geriatric Mental State (GMS) interview, which assess symptoms of depression during the last month \[[@ref020]\]. The GMS interview is a widely used mental-health assessment for older people. The EURO-D symptom scale include 12 depressive symptoms, i.e., depressed mood, pessimism, wishing death, guilt, sleep, interest, irritability, appetite, fatigue, concentration, enjoyment, and tearfulness. Each item score 1 (present symptom) or 0 (no present symptom) \[[@ref021]\]. The scale was originally developed to compare symptoms of late-life depression across European countries in the EURODEP Concerted Action Programme \[[@ref022]\]. A computerized diagnostic algorithm, the AGECAT (Automated Geriatric Examination for Computer Assisted Taxonomy) grouped symptoms to identify diagnoses, according to, e.g., the ICD-10 criteria \[[@ref019]\]. The reliability and validity of the GMS/AGECAT algorithm has been investigated in several previous studies \[[@ref004]\].

Diagnosis of dementia {#sec2030}
---------------------

Dementia was defined through an algorithm authorized by the 10/66 Dementia Research Group \[[@ref026]\]. The algorithm has been calibrated and validated in a large cross-cultural pilot study and is described in details elsewhere \[[@ref017]\]. The diagnosis of dementia was allocated to individuals scoring above a cut-off point of predicted probability for dementia, calculated with coefficients derived from a logistic regression equation, and based on the combined information from: 1) the GMS interview \[[@ref021]\], 2) cognitive tests, i.e., the Community Screening Instrument for Dementia (CSI'D') \[[@ref027]\] and a verbal fluency test \[[@ref028]\], and 3) informant reports of cognitive and functional decline (from the CSI'D' instrument) \[[@ref029]\]. For individuals who died between baseline and follow-up, a postmortem informant interview was used to assess whether there was evidence of cognitive and functional decline \[[@ref026]\]. Participants who were suspected to have died with dementia were coded as 'cases of dementia'.

Potential confounders {#sec2035}
---------------------

A number of socio-demographic and health characteristics were added to the analyses. They were all selected on the basis that they either were assumed to have a potential confounding effect on the association between depression and dementia, or were used in previous studies researching this association. The potential confounders included age (continuous in year), gender (female/male), educational level (none, not completed primary, completed primary, completed secondary and tertiary education), stroke ("*Have you ever been told by a doctor that you had a stroke*?"; coded yes if there was a clear history of sudden onset of unilateral paralysis, loss of speech, or blindness lasting for more than 24 hours) \[[@ref030]\], and diabetes ("*Have you ever been told by a doctor you had diabetes*?" coded yes/no) \[[@ref030]\].

Statistical analyses {#sec2040}
--------------------

First, we analyzed the socio-demographic and health characteristics for each study site and for the total sample. Second, we calculated person-years from the date of baseline examination to 1) the date of death in persons deceased without dementia, 2) the date of follow-up interview in survivors free from dementia, or 3) the date of dementia onset (i.e., the midpoint between the baseline examination and the follow-up examination or postmortem interview). Third, we tested associations between ICD-10 depression and dementia, and sub-syndromal depression and dementia, acknowledging the possibility of a dementia-free death (competing event). The reference group were participants without depression. Sub-hazard ratios (sHR) were derived from Fine and Gray's proportional hazard models \[[@ref031]\]. To test the proportionality of sub-hazards, we included time interactions on all the co-variates as a way of testing the proportional sub-hazards assumption for each. We found that no indication that proportionality assumption had been violated.

Competing risk models were run separately in each site and then pooled together by fixed effect meta-analysis, using inverse-variance weighting together with an estimation of heterogeneity using the Higgins I2. Higgins I2 was computed to estimate the proportion of between-site variability in the estimates accounted for by heterogeneity as opposed to sampling error (up to 40% heterogeneity is conventionally considered negligible, while up to 60% reflects moderate heterogeneity). The 1st model was unadjusted, the 2nd model adjusted for age, gender, and education level, and the 3rd model adjusted for age, gender, education level, stroke, and diabetes.

The statistical significance was defined as a *p*-value \<.05 (two-tailed) in all analyses.

Finally, three additional sensitivity analyses where conducted: 1) a competing risk regression model was used to repeat the analyses and categorizing everyone who died as "deceased without dementia", i.e., not using the postmortem informant information about dementia at time of death ([Supplementary Table 1](#S1){ref-type="supplementary-material"}), 2) we repeated the analyses using Cox regression models instead of competing risk models ([Supplementary Table 2](#S1){ref-type="supplementary-material"}), and finally 3) we repeated the meta-analyses to pool countries together by removing one country at the time, i.e., leave-one-out validation. This was done to assess the impact that each individual site had on the pooled estimates and the robustness of the findings. All data analysis was performed using Stata 13 (StataCorp, College Station, TX, USA).

RESULTS {#sec2045}
=======

The characteristics of the study participants (*n* = 11,472, 64% women) are presented in [Table 1](#jad-69-jad190148-t001){ref-type="table"}. At baseline (mean age = 74.0±6.7), the prevalence of ICD-10 depression was 5%, whereas 21% met the criteria for sub-syndromal depression. Depression and sub-syndromal depression was more common in women than in men (31% versus 18%) and varied between study sites, from 16% in Puerto Rico to 37% in the Dominican Republic. During the 4 years of follow-up, 862 of the participants developed dementia, 736 were detected at the examination, and 126 in the postmortem informant interviews. The incidence of dementia was slightly more common in women than in men (10% versus 8%) and varied from 6% in Peru to 12% in Dominican Republic and Venezuela. One thousand fifty-five participants deceased without a diagnosis of dementia.

###### 

Sociodemographic characteristics of the sample

                                                Cuba        Dominican Republic        Peru          Venezuela          Mexico        Puerto Rico       Across centers
  --------------------------------------- ---------------- -------------------- ---------------- ---------------- ---------------- ---------------- --------------------
  Number of participants at risk, n             2517               1769               1767             1820             1823             1776            **11472**
  Median follow-up to outcome, y (IQR)     4.1 (3.4--5.0)     5.0 (3.3--5.1)     3.0 (2.5--3.7)   4.2 (3.9--4.7)   3.0 (2.9--3.1)   4.3 (3.7--4.7)   **3.8 (2.9--4.7)**
  Mean age at baseline, y (SD)               74.4 (6.6)         74.5 (7.1)         74.2 (6.9)       72.0 (6.4)       73.6 (6.3)       75.4 (6.8)       **74.0 (6.8)**
  Females, n (%)                            1628 (64.7)        1156 (65.4)        1073 (60.7)      1150 (63.2)      1144 (62.8)      1190 (67.3)      **7341 (64.0)**
  Prevalence baseline depression, n (%)                                                                                                             
    ICD-10 depressive episode                118 (4.7)          221 (12.5)          86 (4.9)         84 (4.6)         73 (4.0)         37 (2.0)        **619 (5.4)**
    Sub-syndromal depression                 455 (18.1)         417(23.6)          399 (22.6)       421 (23.1)       424 (23.3)       253 (14.3)      **2369 (20.6)**
    Any depression                           573 (22.8)         638 (36.1)         485 (27.5)       505 (27.7)       497 (27.3)       290 (16.3)      **2988 (26.0)**
  Education level, n (%)                                                                                                                            
    None                                      54 (2.1)          315 (17.9)         103 (5.9)        133 (7.4)        461 (25.3)        47 (2.6)        **1113 (9.7)**
    Some                                     522 (20.8)         917 (52.0)         212 (12.1)       408 (22.6)       802 (44.0)       316 (17.8)      **3177 (27.8)**
    Completed primary                        829 (33.0)         338 (19.2)         654 (37.2)       913 (50.5)       337 (18.5)       358 (20.2)      **3429 (30.0)**
    Completed secondary                      661 (26.3)         126 (7.1)          486 (27.7)       262 (14.5)       117 (6.4)        663 (37.2)      **2315 (20.3)**
    Tertiary (college)                       446 (17.5)          66 (3.7)          301 (17.1)        92 (5.1)        104 (5.7)        385 (21.7)      **1394 (12.2)**
  Stroke, n (%)                              158 (6.3)          118 (6.7)          106 (6.0)        111 (6.1)        120 (6.6)        124 (7.6)        **737 (6.5)**
  Diabetes, n (%)                            466 (18.6)         253 (14.3)         158 (9.0)        283 (15.6)       398 (21.8)       569 (32.2)      **2127 (18.6)**
  Status at follow up                                                                                                                               
    Interviewed, n (%)                      1851 (73.5)        1071 (60.4)        1214 (68.7)      1192 (65.5)      1355 (74.3)      1174 (66.5)       **7857 68.5)**
    Deceased, n (%)                          449 (17.8)         370 (20.9)         109 (6.2)        161 (8.9)        166 (9.1)        200 (11.3)      **1455 (12.7)**
    Lost, n (%)                              217 (8.6)          328 (18.5)         444 (25.1)       467 (25.7)       302 (16.6)       402 (22.7)      **2160 (18.8)**
  Outcome                                                                                                                                           
    Censored, n (%)                         1681 (73.1)         953 (66.1)        1145 (86.6)      1057 (78.1)      1234 (81.1)      1051 (76.5)      **7121 (76.5)**
    Incident dementia, n (%)                 182 (7.9)          165 (11.4)          77 (5.8)        155 (11.5)       130 (8.6)        153 (11.1)       **862 (9.3)**
    Competing risk, n (%)                    437 (19.0)         323 (22.4)         101 (7.6)        141 (10.4)       157 (10.3)       170 (12.4)      **1329 (14.3)**

IQR, interquartile range

In the pooled meta-analysis, people with ICD-10 depression had an 85% increased risk of developing dementia during follow-up period (sHR 1.85, 95% CI 1.44--2.37, I^2^ 45.9%), compared to people without depression ([Table 2](#jad-69-jad190148-t002){ref-type="table"}). The association remained after adjusting for potential confounders (pooled fully adjusted sHR 1.63, 95% CI 1.26--2.11, I^2^ 40.9%). The hazard estimates varied between the study sites. Cuba (sHR 2.53, 95% CI 1.58--4.07) and Venezuela (sHR 2.84, 95% CI 1.62--4.97) had the highest sHR, while Dominican Republic (sHR 1.18, 95% CI 0.75--1.85) and Puerto Rico (sHR 0.76, 95% CI 0.18--3.20) had the lowest observed estimations. Sub-syndromal depression was associated with a 37% increased risk of developing dementia (95% CI 1.17--1.60, I^2^ 53.7%) in the pooled meta-analysis ([Table 3](#jad-69-jad190148-t003){ref-type="table"}).

###### 

Sub-hazard ratios for incident dementia in persons with ICD-10 depressive episode at baseline

                        Unadjusted sHR (95% CI)^a^               Model 2 sHR (95% CI)^a^               Model 3 sHR (95% CI)^a^  
  -------------------- ---------------------------- ----------- ------------------------- ----------- ------------------------- -----------
  Cuba                      2.53 (1.58--4.07)                       2.45 (1.50--4.01)                     2.48 (1.52--4.06)     
  Dominican Republic        1.18 (0.75--1.85)                       1.00 (0.62--1.06)                     1.01 (0.62--1.62)     
  Peru                      1.71 (0.74--3.96)                       1.43 (0.64--3.22)                     1.39 (0.61--3.19)     
  Venezuela                 2.84 (1.62--4.97)                       2.53 (1.40--4.59)                     2.12 (1.16--3.87)     
  Mexico                    1.82 (0.87--3.81)                       1.79 (0.85--3.76)                     1.82 (0.87--3.82)     
  Puerto Rico               0.76 (0.18--3.20)                       0.87 (0.21--3.68)                     0.81 (0.19--3.48)     
                                                       I^2^                                  I^2^                                  I^2^
  **Pooled**              **1.85 (1.44--2.37)**      **45.9%**    **1.38 (1.12--1.68)**    **68.1%**    **1.63 (1.26--2.11)**    **40.9%**

Competing risk models presented using sub-hazard ratios (sHR) and 95% confidence interval (CI). I^2^, Higgins I^2^.; Model 1: unadjusted, Model 2: adjusted for age, gender, and education level, and Model 3: adjusted for age, gender, education level, stroke, and diabetes.; ^a^People with no depression were used as the reference group.

###### 

Sub-hazard ratios for incident dementia in people with sub-syndromal depression at baseline

                        Unadjusted sHR (95% CI)^a^               Model 2 sHR (95% CI)^a^               Model 3 sHR (95% CI)^a^  
  -------------------- ---------------------------- ----------- ------------------------- ----------- ------------------------- -----------
  Cuba                      0.98 (0.66--1.45)                       0.89 (0.59--1.33)                     0.88 (0.59--1.32)     
  Dominican Republic        1.21 (0.85--1.72)                       1.11 (0.78--1.57)                     1.10 (0.77--1.56)     
  Peru                      0.99 (0.57--1.71)                       0.82 (0.46--1.46)                     0.82 (0.47--1.46)     
  Venezuela                 2.10 (1.50--2.95)                       2.22 (1.56--3.14)                     2.13 (1.50--3.03)     
  Mexico                    1.41 (0.96--2.05)                       1.38 (0.94--2.01)                     1.37 (0.93--2.02)     
  Puerto Rico               1.43 (0.96--2.14)                       1.47 (0.97--2.22)                     1.38 (0.90--2.12)     
                                                       I^2^                                  I^2^                                  I^2^
  **Pooled**              **1.37 (1.17--1.60)**      **53.7%**    **1.32 (1.12--1.55)**    **68.7%**    **1.28 (1.09--1.51)**    **66.0%**

Competing risk models presented using sub-hazard ratios (sHR) and 95% confidence interval (CI). I2, Higgins I2.; Model 1: unadjusted, Model 2: adjusted for age, gender, and education level, and Model 3: adjusted for age, gender, education level, stroke, and diabetes.; ^a^people with no depression were used as the reference group.

When the analyses where repeated by categorizing everyone who died as 'deceased without dementia', i.e., not using the postmortem informant information about suspected dementia at time of death, the risk estimation of dementia where similar both for ICD-10 depression (pooled fully adjusted sHR 1.51) and sub-syndromal depression (pooled fully adjusted sHR 1.33) ([Supplementary Table 1](#S1){ref-type="supplementary-material"}). Also the Cox regression models showed similar estimates as the competing risk models, both according to ICD-10 depression (pooled fully adjusted sHR 1.74) and sub-syndromal depression (pooled fully adjusted sHR 1.32) ([Supplementary Table 2](#S1){ref-type="supplementary-material"}).

When repeated the meta-analyses and removing one study at the time, i.e., leave-one-out validation test, in [Table 2](#jad-69-jad190148-t002){ref-type="table"}, the pooled estimates did not change and their 95% CI did not overlap. Removing Venezuela from Model 3 resulted in a pooled estimate of sHR 1.12 (95% CI 0.93--1.34). Removing other countries did not affect the results.

DISCUSSION {#sec2050}
==========

In a large population-based sample of older adults in six defined regions in Latin America, we found that depression was associated with a higher incidence of dementia over a 4-year follow-up period. The strongest associations were observed in people with ICD-10 depression but also in people with sub-syndromal depression (≥4 symptoms in the EURO-D, no confirmed ICD-10 depression) had higher risk of developing dementia. The study sites differed both according to prevalence of depression (e.g., ICD-10 depression ranged from 13% to 25%) and according to the hazard estimates (adjusted sHRs ranged between 0.81 and 2.48 for ICD-10 depression).

To the best of our knowledge, the present 10/66-study is the first longitudinal study examining the association between depressive symptoms and incidence of dementia in LMICs and Latin America. Only a few cross-sectional studies have previously reported on the associations between depression and dementia in older people living in LMIC populations \[[@ref032]\]. The findings are in line with previous published meta-analyses conducted in high-income populations \[[@ref007]\]. A report from Alzheimer's Disease International (ADI) presented pooled data from 32 studies (*n* = 62,598, baseline mean age ranged 70-89 years, median follow-up 5 years) and showed that depression doubled the risk of developing dementia \[[@ref006]\].

The prevalence of cognitive and affective disorders differs between countries and cultures around world. Today, the majority of people with dementia lives in LMICs \[[@ref026]\], and it is estimated that these countries will see the most rapid increase of dementia in the following decades \[[@ref001]\]. In addition, depression is a common health problem in late-life \[[@ref003]\] and population-based studies in LMICs and Latin America report that up to one third of older adults can be affected by depressive symptomatology \[[@ref004]\]. The incidence of depression has, however, considerable variations both in Latin America populations \[[@ref004]\] and in other parts of the world \[[@ref035]\], most likely as a consequence of cultural, demographic, and socio-economic factors. This high variation may also be due to methodological issues and differences in evaluation of symptoms. In the 10/66-study, every effort was made to ensure a conceptual equivalence of all interview questionnaires' items. The research teams underwent substantial training to ensure a consistent approach in the administration of assessments across different cultural settings in accordance with manualized standard operational procedures. The variation in prevalence of depression between the study sites is therefore unlikely to be the result of measurement errors.

The underlying mechanisms by which depression is associated with dementia in older adults are complex and may have several explanations. It remains unclear whether depression itself initiates or worsen the trajectory of dementia, or if depression is an early sign of incipient dementia. The most prominent biological mechanisms that may link depression to dementia are likely to be the results of shared nervous, \[[@ref036]\] vascular, \[[@ref038]\] and inflammatory \[[@ref039]\] pathways. For example, depression increases the activity of the hypothalamic-pituitary-adrenal (HPA) axis and thus the levels of glucocorticoid hormones in the brain, which in turn have been associated with hippocampus atrophy and memory problems \[[@ref036]\]. Depression is also associated with dysregulation in the nervous system, e.g., low serotonin and noradrenaline levels in brain, which have been related to impaired cognitive function \[[@ref037]\]. Another explanation could be that depression is associated with prolonged low-grade inflammation that in the long-term may have a damaging effect on neurons and brain blood vessels \[[@ref040]\].

It is well known that the neurodegenerative processes in the brain often starts many years before a person fulfil the diagnostic criteria for dementia \[[@ref041]\]. Early neurodegenerative changes in the brain may increase the vulnerability to depression and the association between depression and incipient dementia can thus reflect a prodromal state of dementia. In our case, 4 years of follow-up is a relative short period of monitoring, which made it difficult to fully establish the direction of the association, e.g., that the depression itself causes changes that lead to dementia. Cognitive and physical function due to incipient dementia process may also have impact on the mental wellbeing and result in psychiatric symptoms, such as low mood and anxiety \[[@ref042]\].

Cognitive symptoms are common in the context of depression and mood symptoms frequently accompany cognitive disorders. Several symptoms of depression, e.g., concentration problems, sleeping problems, agitation, fatigue, and lack of appetite, are also common in people with dementia, and partly used as diagnostic criteria \[[@ref019]\]. Different types of underlying neuropathology may thus appear as shared clinical symptomatology. The 10/66-study has however no biological measurements, such as magnetic resonance imaging or cerebrospinal fluid markers, to identify specific brain pathologies.

It can be a challenge for clinicians assessing and treating older patients, with co-morbid cognitive and affective symptoms. Studies on psychopharmacology drugs show inconsequent results, and antidepressant treatment has been associated with both increased \[[@ref043]\] and reduced \[[@ref044]\] risk of dementia.

Strength and limitations {#sec2055}
------------------------

The strengths of this study include a large population-based sample in LMICs, a longitudinal study design, face-to-face interviews, and a systematic data collection with identical standardized protocols. Assessment of depression was done by a validated and structured interview that was designed specifically for these older populations, which helped in comparing results across countries using a standardized method. Some methodological issues need however to be considered. First, lack of data on sub-types of dementia, e.g., Alzheimer's disease or vascular dementia, limit our understanding of this association in respect to underlying neurobiological processes. Second, we have no information about the time of onset of depression. It is possible that the association between depression and dementia may be affected by the duration of depression, the numbers of episodes, and the type of treatment received. Third, no information was available on psychopharmacological treatment, i.e., anti-depressant medication or psychological intervention, which can influence the association between depression and dementia. Fourth, some residual confounding factors which were not measured could still exist. For example, other physical and mental health conditions, and lifestyle factors such as, e.g., smoking, alcohol, and stress. Fifth, in people who deceased between baseline and follow-up, information on dementia was assessed using a postmortem informant interview, which may have lower validation than the standardized diagnostically processes from the examinations. The same approach has, however, been used in several previous 10/66 studies \[[@ref045]\], and a sensitivity analysis, which did not include the postmortem information did not show any major difference in regards to the findings. Sixth, cumulative attrition is a problem in long follow-up studies and the participation in the follow-up examination may thus be healthier and have less dementia than the general population. Finally, people with mild cognitive impairment were not excluded from baseline. This could potentially have affected the results of the study, as pathological changes in the brain may have already started occurring in this group of participants.

Conclusion and implications {#sec2060}
---------------------------

Our study found that depression was associated with incidence of dementia over a 4-year follow-up period, even though variation was found across countries. Further research needs to explored more regarding this variance, to understand whether contextual factors may explain these differences. For clinicians, this study strengthens the evidence supporting the importance of a cognitive examination of older people who present with depressive symptoms.
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